Connect with us

Saphris (asenapine)

Asenapine (or SAPHRIS®) is mainly prescribed to treat schizophrenia and bipolar disorder.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2009

Dosage Forms: 2.5 mg, 5 mg, 10 mg

Biological Half-life: 24 hours

Side Effects: Dizziness, weight gain, dysgeusia, fatigue, hypoaesthesia (oral)

Routes of Administration: Sublingual

Pregnancy Category: C (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.